Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Copyright © 2011 by the American Association for the Advancement of Science
Another NOTCH for CancerRuud H. Brakenhoff Squamous cell carcinomas of the head and neck (HNSCCs) that arise in the mucosal linings of the upper respiratory and digestive tracts are the sixth leading cancer by incidence worldwide, with 600,000 new cases each year (1). The most important risk factors for these cancers are tobacco use and alcohol consumption, while a subgroup is caused by infection with human papillomaviruses that also cause cervical cancer (2). Patients with early-stage disease are treated by either surgery or radiotherapy, whereas patients in advanced stages receive a combination of these modalities or concurrent chemotherapy and localized radiation. Only 40 to 50% of patients will survive for 5 years after treatment (2). Antibodies directed against the epidermal growth factor receptor have been the only recent new therapy for this life-threatening disease (3). Two papers in this issue—by Agrawal et al. (4) on page 1154 and Stransky et al. (5) on page 1157—provide new insight into the genetic changes causing HNSCC that may guide the development of alternative treatment strategies.
Department of Otolaryngology/Head-Neck Surgery, VU University Medical Center, 1007 MB Amsterdam, Netherlands. E-mail: rh.brakenhoff{at}vumc.nl
The editors suggest the following Related Resources on Science sites:In Science Magazine
In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882